Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Complivit (Компливит) is a comprehensive multivitamin and mineral supplement developed and manufactured by the Russian pharmaceutical company OTCPharm. It is formulated as a dietary supplement to provide a balanced intake of essential nutrients, including vitamins A, C, E, and the B-complex (B1, B2, B3, B5, B6, B12, folic acid, and biotin), as well as key minerals such as iron, magnesium, zinc, copper, manganese, and selenium. The formulation also includes rutin and lipoic acid. Complivit is specifically designed to address the nutritional needs associated with the traditional Russian diet and utilizes a specialized granulation technology to ensure the stability and compatibility of its diverse components within a single tablet. It is primarily indicated for the prevention and treatment of vitamin and mineral deficiencies and for supporting overall metabolic health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Complivit.